Paydirt
CF
Insider

Chris Freeman

Chief Commercial Officer

Chris Freeman (Chief Commercial Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Guardant Health, Inc. (GH). The largest single filing was $10.8M of GH (63,605 sh across 4 lots, as filed), executed Aug 10.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$16.7M
shares × price, as filed
Last traded
Aug 10
Filed Aug 11

Median ADV $437.7M across their filed names

Open performance
Volume by month
$10.8M$5.4M$0Oct 2024Apr 2025Oct 2025Apr 2026Dec 2025 · sells $3.0MMay 2026 · sells $2.9MAug 2026 · sells $10.8M
Buys $0 Sells $16.7M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names
GH Guardant Health, Inc. GH · 0 buys · 3 sells 3 filings
Recent filings
GHSALE Guardant Health, Inc. View filing → $10.8M
63,605 sh across 4 lots
Exec Aug 10
Filed Aug 11 · 6:22 PM ET
GHSALE Guardant Health, Inc. View filing → $2.9M
24,406 sh × $118.67
Exec May 22
Filed May 26 · 5:30 PM ET
GHSALE Guardant Health, Inc. View filing → $3.0M
28,986 sh across 5 lots
Exec Dec 5 2025
Filed Dec 8 2025 · 5:30 PM ET